«Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making». PharmacoEconomics24 (6): 523–35. 2006. doi:10.2165/00019053-200624060-00001. PMID16761901.
«Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making». PharmacoEconomics24 (6): 523–35. 2006. doi:10.2165/00019053-200624060-00001. PMID16761901.